Big Law
Pharmaceutical Company, Novartis, Files a Lawsuit Against Entresto Over Allegations of Patent Infringement of Popular Drug
Novartis is already suing a long list of generics producers that aim to bring copycats of the company’s popular heart failure drug Entresto to market. Now, the Swiss pharma itself has become target in a patent infringement lawsuit.
Entresto infringes a co-crystal patent held by the University of Michigan and the University of South Florida, the two institutions alleged in a complaint filed Monday in the U.S. District Court for the Northern District of California.
The universities are seeking a jury trial and damages to compensate for the alleged patent infringement. Since Entresto is a blockbuster that generated $3.55 billion worldwide last year, the damages, if awarded, could wind up being significant.
